Clinical Trial Update: Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Phase 1]

View source ↗

Summary

An early-phase antibody therapy was tested in patients with relapsed or refractory Non-Hodgkin lymphoma and Chronic lymphocytic leukemia; the Phase 1 study was …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Non-hodgkin Lymphoma

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Leukemia, Lymphoma | Phase 1 | Status: TERMINATED | Results posted: 2013-08-05